Health
NIH-Moderna Investigational COVID-19 Vaccine Shows Promise – SciTechDaily
Vaccine shows promise in mouse studies and is currently being evaluated in Phase 3 clinical testing. The investigational vaccine known as mRNA-1273 protected mice from infection with SARS-CoV-2, the virus that causes COVID-19, according to research published …
Colorized scanning electron micrograph of a VERO E6 cell (blue) heavily infected with SARS-COV-2 virus particles (orange), isolated from a patient sample. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: NIAID
Vaccine shows promise in mouse studies and is currently being evaluated in Phase 3 clinical testing.
The investigational vaccine known as mRNA-1273 protected mice from infection with SARS-CoV-2, the virus that causes COV…
-
Noosa News23 hours agoReubhan Ralph identified as man behind terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
General21 hours agoPolice say new leads being pursued after baby’s body found in Alexander Heights stormwater drain
-
Noosa News24 hours agoSchoolgirls hit by fishtailing car in terrifying crash in Bellbird Park, Ipswich
-
Noosa News21 hours agoPolice charge second man over alleged assault in Gold Coast car seller on Facebook’s Marketplace